Icahn Sues Amylin Pharmaceuticals Asking for Books, Records

Billionaire investor Carl Icahn sued Amylin Pharmaceuticals demanding records related to a $3.5 billion takeover offer by Bristol-Myers Squibb as he seeks to start a proxy fight against Amylin’s board.
Bloomberg